165 related articles for article (PubMed ID: 29141812)
1. Neuromyelitis optica spectrum disorders in Iran.
Eskandarieh S; Nedjat S; Azimi AR; Moghadasi AN; Sahraian MA
Mult Scler Relat Disord; 2017 Nov; 18():209-212. PubMed ID: 29141812
[TBL] [Abstract][Full Text] [Related]
2. Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: A case-control study.
Eskandarieh S; Nedjat S; Abdollahpour I; Moghadasi AN; Azimi AR; Sahraian MA
Mult Scler Relat Disord; 2017 Feb; 12():39-43. PubMed ID: 28283104
[TBL] [Abstract][Full Text] [Related]
3. Neuromyelitis optica spectrum disorder and menstruation.
Badihian S; Manouchehri N; Mirmosayyeb O; Ashtari F; Shaygannejad V
Rev Neurol (Paris); 2018 Dec; 174(10):716-721. PubMed ID: 30049560
[TBL] [Abstract][Full Text] [Related]
4. Environmental risk factors in neuromyelitis optica spectrum disorder: a case-control study.
Eskandarieh S; Nedjat S; Abdollahpour I; Azimi AR; Moghadasi AN; Asgari N; Sahraian MA
Acta Neurol Belg; 2018 Jun; 118(2):277-287. PubMed ID: 29500680
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
[TBL] [Abstract][Full Text] [Related]
6. Stressful life events, socioeconomic status, and the risk of neuromyelitis optica spectrum disorder: A population-based case-control study.
Rafiee F; Tarjoman T; Moghadasi AN; Sahraian MA; Azimi A; Rezaeimanesh N; Eskandarieh S
Mult Scler Relat Disord; 2020 Nov; 46():102544. PubMed ID: 33032056
[TBL] [Abstract][Full Text] [Related]
7. Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis.
Bagherieh S; Afshari-Safavi A; Vaheb S; Kiani M; Ghaffary EM; Barzegar M; Shaygannejad V; Zabeti A; Mirmosayyeb O
Neurol Sci; 2023 Jun; 44(6):1905-1915. PubMed ID: 36745300
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution.
Bizzoco E; Lolli F; Repice AM; Hakiki B; Falcini M; Barilaro A; Taiuti R; Siracusa G; Amato MP; Biagioli T; Lori S; Moretti M; Vinattieri A; Nencini P; Massacesi L; Matà S
J Neurol; 2009 Nov; 256(11):1891-8. PubMed ID: 19479168
[TBL] [Abstract][Full Text] [Related]
9. Neuromyelitis optica in Portugal (NEMIPORT) - A multicentre study.
Domingos J; Isidoro L; Figueiredo R; Brum M; Capela C; Barros P; Santos E; Macário Mdo C; Pinto Marques J; Pedrosa R; Vale J; Sá MJ
Clin Neurol Neurosurg; 2015 Jul; 134():79-84. PubMed ID: 25965287
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of neuromyelitis optica in the United States: a multicenter analysis.
Mealy MA; Wingerchuk DM; Greenberg BM; Levy M
Arch Neurol; 2012 Sep; 69(9):1176-80. PubMed ID: 22733096
[TBL] [Abstract][Full Text] [Related]
11. Low T3 syndrome in neuromyelitis optica spectrum disorder: Associations with disease activity and disability.
Cho EB; Min JH; Cho HJ; Seok JM; Lee HL; Shin HY; Lee KH; Kim BJ
J Neurol Sci; 2016 Nov; 370():214-218. PubMed ID: 27772762
[TBL] [Abstract][Full Text] [Related]
12. Neuromyelitis Optica Spectrum Disorders in Africa: A Systematic Review.
Musubire AK; Derdelinckx J; Reynders T; Meya DB; Bohjanen PR; Cras P; Willekens B
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34663674
[TBL] [Abstract][Full Text] [Related]
13. Psychiatric comorbidities and suicidality among patients with neuromyelitis optica spectrum disorders in Argentina.
Fernández VC; Alonso N; Melamud L; Villa AM
Mult Scler Relat Disord; 2018 Jan; 19():40-43. PubMed ID: 29125969
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of quality of life, anxiety, depression, and fatigue among patients with neuromyelitis optica spectrum disorder and multiple sclerosis: The first report from Iran.
Barzegar M; Badihian S; Mirmosayyeb O; Ashtari F; Jamadi M; Emami S; Jahani L; Safavi A; Shaygannejad V
Mult Scler Relat Disord; 2018 May; 22():161-165. PubMed ID: 29775851
[TBL] [Abstract][Full Text] [Related]
15. Gender differences among Chinese patients with neuromyelitis optica spectrum disorders.
Sun H; Sun X; Li J; Huo Y; Wu L; Huang D; Yu S; Wu W
Mult Scler Relat Disord; 2017 Oct; 17():5-8. PubMed ID: 29055474
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and prognosis of late-onset neuromyelitis optica spectrum disorders in a Latin American cohort.
Carnero Contentti E; Daccach Marques V; Soto de Castillo I; Tkachuk V; Ariel B; Castillo MC; Cristiano E; Diégues Serva GB; Dos Santos AC; Finkelsteyn AM; López PA; Patrucco L; Molina O; Pettinicchi JP; Toneguzzo V; Caride A; Rojas JI
J Neurol; 2020 May; 267(5):1260-1268. PubMed ID: 31932911
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic neuromyelitis optica spectrum disorders: three new cases and a review of the literature.
Cai G; He D; Chu L; Dai Q; Xu Z; Zhang Y
Int J Neurosci; 2016; 126(7):660-8. PubMed ID: 26010208
[TBL] [Abstract][Full Text] [Related]
18. Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features.
Altintas A; Karabudak R; Balci BP; Terzi M; Soysal A; Saip S; Tuncer Kurne A; Uygunoglu U; Nalbantoglu M; Gozubatik Celik G; Isik N; Celik Y; Gokcay F; Duman T; Boz C; Yucesan C; Mangan MS; Celebisoy N; Diker S; Colpak Isikay I; Kansu T; Siva A
Neurologist; 2015 Oct; 20(4):61-6. PubMed ID: 26468870
[TBL] [Abstract][Full Text] [Related]
19. Patient perspectives on neuromyelitis optica spectrum disorders: Data from the PatientsLikeMe online community.
Eaneff S; Wang V; Hanger M; Levy M; Mealy MA; Brandt AU; Eek D; Ratchford JN; Nyberg F; Goodall J; Wicks P
Mult Scler Relat Disord; 2017 Oct; 17():116-122. PubMed ID: 29055439
[TBL] [Abstract][Full Text] [Related]
20. Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis.
Kim SH; Kwak K; Jeong IH; Hyun JW; Jo HJ; Joung A; Yu ES; Kim JH; Lee SH; Yun S; Joo J; Lee DK; Lee JM; Kim HJ
Mult Scler; 2016 Dec; 22(14):1850-1858. PubMed ID: 26920380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
